Tong Ren Tang Technologies Co. Ltd. (TGRNF)
USD 0.69
(0.0%)
USD 0.69
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.11 Billion CNY | 47.37% |
| 2022 | -2.12 Billion CNY | -32.72% |
| 2021 | -1.6 Billion CNY | -27.09% |
| 2020 | -1.26 Billion CNY | 17.42% |
| 2019 | -1.52 Billion CNY | -92.66% |
| 2018 | -792.55 Million CNY | 11.77% |
| 2017 | -898.28 Million CNY | 25.36% |
| 2016 | -1.2 Billion CNY | 11.05% |
| 2015 | -1.35 Billion CNY | 19.19% |
| 2014 | -1.67 Billion CNY | 5.59% |
| 2013 | -1.77 Billion CNY | -147.93% |
| 2012 | -715.35 Million CNY | -30.85% |
| 2011 | -546.69 Million CNY | -28.3% |
| 2010 | -426.1 Million CNY | -23.27% |
| 2009 | -345.66 Million CNY | -39.22% |
| 2008 | -248.29 Million CNY | -7.44% |
| 2007 | -231.09 Million CNY | -94.96% |
| 2006 | -118.53 Million CNY | 2.2% |
| 2005 | -121.2 Million CNY | -9.26% |
| 2004 | -110.93 Million CNY | 1.94% |
| 2003 | -113.13 Million CNY | 50.13% |
| 2002 | -226.86 Million CNY | -52.7% |
| 2001 | -148.56 Million CNY | 44.06% |
| 2000 | -265.55 Million CNY | -997.34% |
| 1999 | 29.59 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.7 Billion CNY | -52.4% |
| 2024 Q2 | -1.7 Billion CNY | 0.0% |
| 2023 Q2 | -2.4 Billion CNY | 2.93% |
| 2023 FY | -1.11 Billion CNY | 47.37% |
| 2023 Q1 | -2.48 Billion CNY | -16.67% |
| 2023 Q4 | -1.11 Billion CNY | 6.25% |
| 2023 Q3 | -1.19 Billion CNY | 50.43% |
| 2022 Q1 | -1.09 Billion CNY | 31.65% |
| 2022 Q2 | -1.03 Billion CNY | 5.67% |
| 2022 Q3 | -2.17 Billion CNY | -110.5% |
| 2022 Q4 | -2.12 Billion CNY | 2.21% |
| 2022 FY | -2.12 Billion CNY | -32.72% |
| 2021 Q2 | -1.9 Billion CNY | 3.28% |
| 2021 Q4 | -1.6 Billion CNY | 3.83% |
| 2021 Q1 | -1.96 Billion CNY | -55.84% |
| 2021 FY | -1.6 Billion CNY | -27.09% |
| 2021 Q3 | -1.66 Billion CNY | 12.33% |
| 2020 FY | -1.26 Billion CNY | 17.42% |
| 2020 Q1 | -2.2 Billion CNY | -44.73% |
| 2020 Q2 | -2.17 Billion CNY | 1.7% |
| 2020 Q3 | -1.31 Billion CNY | 39.53% |
| 2020 Q4 | -1.26 Billion CNY | 4.01% |
| 2019 Q3 | -1.56 Billion CNY | -102.4% |
| 2019 Q1 | -818.91 Million CNY | -3.33% |
| 2019 Q2 | -774.3 Million CNY | 5.45% |
| 2019 Q4 | -1.52 Billion CNY | 2.57% |
| 2019 FY | -1.52 Billion CNY | -92.66% |
| 2018 Q1 | -709.46 Million CNY | 21.02% |
| 2018 Q4 | -792.55 Million CNY | 0.0% |
| 2018 FY | -792.55 Million CNY | 11.77% |
| 2018 Q2 | -709.46 Million CNY | 0.0% |
| 2018 Q3 | -792.55 Million CNY | -11.71% |
| 2017 Q2 | -1.01 Billion CNY | 0.0% |
| 2017 Q4 | -898.28 Million CNY | 0.0% |
| 2017 FY | -898.28 Million CNY | 25.36% |
| 2017 Q3 | -898.28 Million CNY | 11.06% |
| 2017 Q1 | -1.01 Billion CNY | 16.08% |
| 2016 Q1 | -1.72 Billion CNY | -27.37% |
| 2016 Q2 | -1.72 Billion CNY | 0.0% |
| 2016 Q3 | -1.2 Billion CNY | 30.16% |
| 2016 Q4 | -1.2 Billion CNY | 0.0% |
| 2016 FY | -1.2 Billion CNY | 11.05% |
| 2015 FY | -1.35 Billion CNY | 19.19% |
| 2015 Q1 | -1.67 Billion CNY | 0.15% |
| 2015 Q2 | -1.67 Billion CNY | 0.0% |
| 2015 Q3 | -1.36 Billion CNY | 18.28% |
| 2015 Q4 | -1.35 Billion CNY | 0.96% |
| 2014 Q3 | -1.67 Billion CNY | 8.1% |
| 2014 Q1 | -1.82 Billion CNY | -2.72% |
| 2014 Q4 | -1.67 Billion CNY | 0.0% |
| 2014 FY | -1.67 Billion CNY | 5.59% |
| 2014 Q2 | -1.82 Billion CNY | 0.0% |
| 2013 Q4 | -1.77 Billion CNY | 0.0% |
| 2013 FY | -1.77 Billion CNY | -147.93% |
| 2013 Q3 | -1.77 Billion CNY | -32.56% |
| 2013 Q2 | -1.33 Billion CNY | 0.0% |
| 2013 Q1 | -1.33 Billion CNY | -87.04% |
| 2012 FY | -715.35 Million CNY | -30.85% |
| 2012 Q2 | -676.55 Million CNY | 0.0% |
| 2012 Q4 | -715.35 Million CNY | 0.0% |
| 2011 Q4 | -546.69 Million CNY | 0.0% |
| 2011 FY | -546.69 Million CNY | -28.3% |
| 2011 Q2 | -708.38 Million CNY | 0.0% |
| 2010 Q2 | -439.48 Million CNY | 0.0% |
| 2010 Q4 | -426.1 Million CNY | 0.0% |
| 2010 FY | -426.1 Million CNY | -23.27% |
| 2009 Q4 | -345.66 Million CNY | 0.0% |
| 2009 FY | -345.66 Million CNY | -39.22% |
| 2008 FY | -248.29 Million CNY | -7.44% |
| 2007 FY | -231.09 Million CNY | -94.96% |
| 2006 FY | -118.53 Million CNY | 2.2% |
| 2005 FY | -121.2 Million CNY | -9.26% |
| 2004 FY | -110.93 Million CNY | 1.94% |
| 2003 FY | -113.13 Million CNY | 50.13% |
| 2002 FY | -226.86 Million CNY | -52.7% |
| 2001 FY | -148.56 Million CNY | 44.06% |
| 2000 FY | -265.55 Million CNY | -997.34% |
| 1999 FY | 29.59 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AstraZeneca PLC | 22.74 Billion USD | 104.92% |
| Bristol-Myers Squibb Company PFD CONV 2 | 30 Billion USD | 103.731% |
| CSPC Pharmaceutical Group Limited | -1.59 Billion USD | 29.786% |
| Clarus Therapeutics Holdings, Inc. | 15.85 Million USD | 7159.695% |
| Novartis AG | 12.95 Billion USD | 108.639% |
| PT Kalbe Farma Tbk. | -169.7 Million USD | -559.537% |